article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands. and Europe.

article thumbnail

Bolstering Health Technology Assessment With the Help of AI

Pharmaceutical Commerce

Artificial intelligence addresses key limitations of traditional health technology assessments—such as data gaps and time-intensive processes—through automation, real-time data integration, and advanced predictive modeling, leading to faster and more informed decisions. In order to automate and enhance these tasks, AI-driven NLP can assist.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Formularies, Formulary Strategies, and Vigilante Formulary Review

Ramblings of a pharmacist

Health insurance providers do the same, and usually outsource this function to Pharmacy Benefit Managers. We can also see from this excerpt that at the scale of large PBMs, formulary strategies are also a piece of negotiating leverage to obtain rebates and fees from pharmaceutical manufacturers.

article thumbnail

Policy Whiplash? 24 Hours in the Hub Still Matters More

Pharmaceutical Commerce

With ongoing policy uncertainty, hubs must prioritize adaptable, resilient designs—focusing on process speed, modularity, data tracking, and selecting partners who can evolve with regulatory change. Future-Proofing Hubs is a Must.

article thumbnail

Popping the Gross-to-Net Bubble, Part IV: Extreme Examples of Who Grew the Bubble

Pharmaceutical Commerce

It is fair to say that the pharmacy benefit managers (PBMs) enabled it, but pharmaceutical manufacturers took advantage of it. PBMs contractually allowed pharmaceutical manufacturers to raise list prices within their annual contracts to a negotiated ceiling. It does indeed take two to tango. to $750 per pill.

article thumbnail

Building Intelligent Pharma Supply Chain Management with Real-World Data

Pharmaceutical Commerce

They also experience some of the same problems that manufacturers and distributors face, like spotty tracking information due to the manual processes associated with barcode scanning of drugs. Large hospital systems, for example, have medications distributed among many different pharmacies and departments.

article thumbnail

Pharmacy Policy Updates for June 2025

Pharmacy Times

The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers.